CLINICAL STUDY: ELECTROPHYSIOLOGY
Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels
Bianca J. J. M. Brundel, MSc*  ,
Isabelle C. Van Gelder, MD*,
Robert H. Henning, MD,
Anton E. Tuinenburg, MD*,
Mirian Wietses,
Jan G. Grandjean, MD ,
Arthur A. M. Wilde, MD ,
Wiek H. Van Gilst, PhD and
Harry J. G. M. Crijns, MD*
* Department of Cardiology, Thoraxcenter University Hospital Groningen, Groningen, The Netherlands
Department of Clinical Pharmacology, Thoraxcenter University Hospital Groningen, Groningen, The Netherlands
Department of Thoracic Surgery, Thoraxcenter University Hospital Groningen, Groningen, The Netherlands
Department of Cardiology, University of Amsterdam, Utrecht, The Netherlands
Manuscript received October 22, 1999;
revised manuscript received September 25, 2000,
accepted November 3, 2000.
Reprint requests and correspondence: Dr. Isabelle Van Gelder, Department of Cardiology Thoraxcenter, University Hospital Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands
I.C.van.Gelder{at}thorax.azg.nl
OBJECTIVES
Our purpose was to determine whether patients with persistent atrial fibrillation (AF) and patients with paroxysmal AF show alterations in potassium channel expression.
BACKGROUND
Persistent AF is associated with a sustained shortening of the atrial action potential duration and atrial refractory period. Underlying molecular changes have not been studied in humans. We investigated whether a changed gene expression of specific potassium channels is associated with these changes in patients with persistent AF and in patients with paroxysmal AF.
METHODS
Right atrial appendages were obtained from 8 patients with paroxysmal AF, 10 with persistent AF and 18 matched controls in sinus rhythm. All controls underwent coronary artery bypass surgery, whereas most AF patients underwent Cox’s MAZE surgery (atrial arrhythmia surgery to cure AF) (n = 12). All patients had normal left ventricular function. mRNA (ribonucleic acid) levels were measured by semiquantitative polymerase chain reaction and protein content by Western blotting.
RESULTS
mRNA levels of transient outward channel (Kv4.3), acetylcholine-dependent potassium channel (Kir3.4) and ATP-dependent potassium channel (Kir6.2) were reduced in patients with persistent AF (–35%, –47% and –36%, respectively, p < 0.05), whereas only Kv4.3 mRNA level was reduced in patients with paroxysmal AF (–29%, p = 0.03). No changes were found for Kv1.5 and HERG mRNA levels in either group. Protein levels of Kv4.3, Kv1.5 and Kir3.1 were reduced both in patients with persistent AF (–39%, –84% and –47%, respectively, p < 0.05) and in those with paroxysmal AF (–57%, –64%, and –40%, respectively, p < 0.05).
CONCLUSIONS
Persistent AF is accompanied by reductions in mRNA and protein levels of several potassium channels. In patients with paroxysmal AF these reductions were observed predominantly at the protein level and not at the mRNA level, suggesting a post-transcriptional regulation.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | CABG | = coronary artery bypass surgery | | DNA | = deoxyribonucleic acid | | GAPDH | = glyceraldehyde-3-phosphate dehydrogenase | | HERG | = gene encoding rapid component of the delayed rectifier IKr | | Kir3.1 | = gene encoding part of the IKACh, together with IKir3.4 | | Kir3.4 | = gene encoding part of the IKACh, together with IKir3.1 | | Kir6.2 | = gene encoding part of the IKATP | | Kv1.5 | = gene encoding ultra rapid component of the delayed rectifier IKur | | Kv4.3 | = gene underlying calcium independent transient outward current ITo1 | | LV | = left ventricular, left ventricle | | NYHA | = New York Heart Association | | PCR | = polymerase chain reaction | | RNA | = ribonucleic acid | | SR | = sinus rhythm |
|
This article has been cited by other articles:
|
|
|
|
 
A. Sridhar, Y. Nishijima, D. Terentyev, M. Khan, R. Terentyeva, R. L. Hamlin, T. Nakayama, S. Gyorke, A. J. Cardounel, and C. A. Carnes
Chronic heart failure and the substrate for atrial fibrillation
Cardiovasc Res,
November 1, 2009;
84(2):
227 - 236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Pretorius, X.-J. Du, E. A. Woodcock, H. Kiriazis, R. C.Y. Lin, S. Marasco, R. L. Medcalf, Z. Ming, G. A. Head, J. W. Tan, et al.
Reduced Phosphoinositide 3-Kinase (p110{alpha}) Activation Increases the Susceptibility to Atrial Fibrillation
Am. J. Pathol.,
September 1, 2009;
175(3):
998 - 1009.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. McEwen and J. R. Martens
Antifibrillatory Agents and Potassium Channels in the Atria: Pore Block versus Channel Trafficking
Mol. Interv.,
April 1, 2009;
9(2):
79 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Michael, L. Xiao, X.-Y. Qi, D. Dobrev, and S. Nattel
Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis
Cardiovasc Res,
February 15, 2009;
81(3):
491 - 499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Ravens and E. Cerbai
Role of potassium currents in cardiac arrhythmias
Europace,
October 1, 2008;
10(10):
1133 - 1137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nattel, B. Burstein, and D. Dobrev
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Circ Arrhythm Electrophysiol,
April 1, 2008;
1(1):
62 - 73.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tsujimae, S. Murakami, and Y. Kurachi
In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H793 - H800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. L. Tan, J. P.P. Smits, A. Loef, M. W.T. Tanck, M. Hardziyenka, and M. E. Campian
Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation
Europace,
January 1, 2008;
10(1):
99 - 104.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Mintert, L. I. Bosche, A. Rinne, M. Timpert, M.-C. Kienitz, L. Pott, and K. Bender
Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4
J. Physiol.,
November 15, 2007;
585(1):
3 - 13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Stanfield
Homomers of Kir.3.4 in atrial myocytes: their relevance to atrial fibrillation
J. Physiol.,
November 15, 2007;
585(1):
1 - 1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. McEwen, S. M. Schumacher, Q. Li, M. D. Benson, J. A. Iniguez-Lluhi, K. M. Van Genderen, and J. R. Martens
Rab-GTPase-dependent Endocytic Recycling of KV1.5 in Atrial Myocytes
J. Biol. Chem.,
October 5, 2007;
282(40):
29612 - 29620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Saygili, O. R. Rana, E. Saygili, H. Reuter, K. Frank, R. H. G. Schwinger, J. Muller-Ehmsen, and C. Zobel
Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes
Am J Physiol Heart Circ Physiol,
June 1, 2007;
292(6):
H2898 - H2905.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Voigt, A. Friedrich, M. Bock, E. Wettwer, T. Christ, M. Knaut, R. H. Strasser, U. Ravens, and D. Dobrev
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation
Cardiovasc Res,
June 1, 2007;
74(3):
426 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev,
April 1, 2007;
87(2):
425 - 456.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Baro
Atrial fibrillation: Is NO an answer for refractoriness?
Cardiovasc Res,
October 1, 2006;
72(1):
7 - 8.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Dobrev, A. Friedrich, N. Voigt, N. Jost, E. Wettwer, T. Christ, M. Knaut, and U. Ravens
The G Protein-Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation
Circulation,
December 13, 2005;
112(24):
3697 - 3706.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. M. Kim, T. J. Guzik, Y. H. Zhang, M. H. Zhang, H. Kattach, C. Ratnatunga, R. Pillai, K. M. Channon, and B. Casadei
A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation
Circ. Res.,
September 30, 2005;
97(7):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Gaborit, M. Steenman, G. Lamirault, N. Le Meur, S. Le Bouter, G. Lande, J. Leger, F. Charpentier, T. Christ, D. Dobrev, et al.
Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation
Circulation,
July 26, 2005;
112(4):
471 - 481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Duytschaever, Y. Blaauw, and M. Allessie
Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs
Cardiovasc Res,
July 1, 2005;
67(1):
69 - 76.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Dobrev, T. Christ, and U. Ravens
Muscarinic subtype-2 receptor autoantibodies: actors or bystanders in human atrial fibrillation?
Eur. Heart J.,
July 1, 2004;
25(13):
1091 - 1092.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Baba, T. Yoshikawa, Y. Fukuda, T. Sugiyama, M. Shimada, M. Akaishi, K. Tsuchimoto, S. Ogawa, and M. Fu
Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy
Eur. Heart J.,
July 1, 2004;
25(13):
1108 - 1115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Birnbaum, A. W. Varga, L.-L. Yuan, A. E. Anderson, J. D. Sweatt, and L. A. Schrader
Structure and Function of Kv4-Family Transient Potassium Channels
Physiol Rev,
July 1, 2004;
84(3):
803 - 833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. BORLAK and T. THUM
Hallmarks of ion channel gene expression in end-stage heart failure
FASEB J,
September 1, 2003;
17(12):
1592 - 1608.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Valenzuela
Pharmacological electrical remodelling in human atria induced by chronic {beta}-blockade
Cardiovasc Res,
June 1, 2003;
58(3):
498 - 500.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shimizu and O. A. Centurion
Electrophysiological properties of the human atrium in atrial fibrillation
Cardiovasc Res,
May 1, 2002;
54(2):
302 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res,
May 1, 2002;
54(2):
315 - 324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J.J.M Brundel, J. Ausma, I. C van Gelder, J. J.L Van Der Want, W. H van Gilst, H. J.G.M Crijns, and R. H Henning
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation
Cardiovasc Res,
May 1, 2002;
54(2):
380 - 389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. L.J.L Thijssen, H. M.W van der Velden, E. P van Ankeren, J. Ausma, M. A Allessie, M. Borgers, G. J.J.M van Eys, and H. J Jongsma
Analysis of altered gene expression during sustained atrial fibrillation in the goat
Cardiovasc Res,
May 1, 2002;
54(2):
427 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. L.J.L. Thijssen, J. Ausma, and M. Borgers
Structural remodelling during chronic atrial fibrillation: act of programmed cell survival
Cardiovasc Res,
October 1, 2001;
52(1):
14 - 24.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
